Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 Omnicell (Nasdaq:OMCL) will release fourth quarter and full year 2025 financial results before market open on Thursday, February 5, 2026. Management will host a conference call and webcast to discuss results at 8:30 a.m. ET the same day.Investors can join by dialing (800) 715-9871 (U.S.) or (646) 307-1963 (international) using Conference ID 4203777. A live and archived webcast will be available on Omnicell's Investor Relations events page at https://ir.omnicell.com/events-and-presentations/.

#OMCL Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

www.stocktitan.net/news/OMCL/omnicell-to-re...

#OMCL Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies

www.stocktitan.net/news/OMCL/omnicell-achie...

Trade Alert, Wednesday November 5, 2025 – Crystal Equity Research

Small-cap stocks in new uptrend, Ave Dir Indx, Wed Nov 5th - #HMR #PVBC #OMCL #NPCE #LOCO #HLIT #GDYN #TYG #SD #OOMA #CXW - More: crystalequityresearch.com/trade-alert-... - #smallcap

Omnicell Announces Third Quarter 2025 Financial Results Total revenues for the third quarter of 2025 were $311 million, up $28 million, or 10%, from the third quarter of 2024. Total GAAP net income for the third quarter of 2025 was $5 million, or $0.12 per diluted share. This compares to GAAP net income of $9 million, or $0.19 per diluted share, for the third quarter of 2024..

#OMCL Omnicell Announces Third Quarter 2025 Financial Results

www.stocktitan.net/news/OMCL/omnicell-annou...

Omnicell Announces Second Quarter 2025 Results Omnicell (NASDAQ:OMCL) reported strong Q2 2025 financial results, exceeding previous guidance. Total revenues reached $291 million, up 5% year-over-year, with GAAP net income of $6 million ($0.12 per share) and non-GAAP net income of $21 million ($0.45 per share).The company maintains a solid balance sheet with $399 million in cash and equivalents, while operating cash flow was $43 million. Notable achievements include the launch of MedVision and MedTrack/MedTrack-OR solutions, HITRUST CSF i1 certification for OmniSphere, and the opening of a new Innovation Lab in Austin.Based on strong H1 2025 performance, Omnicell raised its full-year 2025 guidance, projecting total revenues of $1.13-1.16 billion and non-GAAP EPS of $1.40-1.65.

#OMCL Omnicell Announces Second Quarter 2025 Results

www.stocktitan.net/news/OMCL/omnicell-annou...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Wed Jun 4th - #PTON #STSS #VLRS #UUUU #UEC #TRMD #SPCB #SGMT #SEDG #RCAT #QUBT #OMCL #MULN #EVH #DDD #DBVT #BTCS #BORR #BMGL #FSM - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Omnicell Boosts Q2 EPS Guidance by 26%, Announces Fresh $75M Share Repurchase Plan China tariff reduction drives 26% increase in Q2 EPS guidance. Board authorizes new $75M share repurchase program, signaling confidence. See full outlook update.

#OMCL Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program

www.stocktitan.net/news/OMCL/omnicell-expec...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with bullish moving average convergence divergence crossovers, Wed May 14th - #UNIT #TLS #SRDX #PAL #OMCL #LUCD #KGEI #GURE #ENSC #CLNN #BLUE #AUDC #VOC #UTZ #NCDL #KODK #CIA #ARIS - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Omnicell Unveils Game-Changing RFID System That Could Transform Operating Room Efficiency New RFID-enabled MedTrack system automates OR medication tracking while MedVision software streamlines clinic inventory. See how these innovations boost efficiency.

#OMCL Omnicell Announces New Products for Perioperative and Clinic Settings

www.stocktitan.net/news/OMCL/omnicell-annou...

Omnicell Announces First Quarter 2025 Results Omnicell (NASDAQ:OMCL) reported Q1 2025 financial results exceeding previous guidance. Total revenues reached $270 million, up 10% year-over-year, driven by growth in XT Amplify program and SaaS services. The company posted a GAAP net loss of $7 million ($0.15 per share), improving from a $16 million loss in Q1 2024. Non-GAAP net income was $12 million ($0.26 per share). The company maintains a strong balance sheet with $387 million in cash and equivalents. However, due to potential tariff impacts, Omnicell updated its full-year 2025 guidance, now expecting total revenues of $1.105-1.155 billion and non-GAAP earnings per share of $1.00-1.65. The company is expanding its presence with new facilities in Austin and Bangalore to enhance product development and cloud strategy.

#OMCL Omnicell Announces First Quarter 2025 Results

www.stocktitan.net/news/OMCL/omnicell-annou...

omnicell logo, the insiders fund logo, overlaying a pharmacy shelve, with a person holding a basket with prescription, and opinion: Opinion: CEO's purchase is notable, but Amazon's entry into this space makes this investment risky.

INSIDER BUY: Omnicell $OMCL CEO buys $350K in shares 💰
Our take: Nervous about this one with Amazon entering the healthcare space. Proceed with caution.
Full analysis: bit.ly/41RKlrz
#InsiderBuying #OMCL #NotInvestmentAdvice

omnicell logo, the insiders fund logo, overlaying a pharmacy shelve, with a person holding a basket with prescription, and opinion: Opinion: CEO's purchase is notable, but Amazon's entry into this space makes this investment risky.

INSIDER BUY: Omnicell $OMCL CEO buys $350K in shares 💰
Our take: Nervous about this one with Amazon entering the healthcare space. Proceed with caution.
Full analysis: bit.ly/41Trexq
#InsiderBuying #OMCL #NotInvestmentAdvice

Omnicell CFO Exit Won't Disrupt Growth: Company Reaffirms Strong 2025 Outlook Omnicell maintains 2025 financial targets as CFO Nchacha Etta announces planned departure. Orderly transition planned with focus on continued operational efficiency and strategic growth.

#OMCL Omnicell Announces Chief Financial Officer Transition

www.stocktitan.net/news/OMCL/omnicell-annou...

Omnicell Delivers Massive Q4 Turnaround: Revenue Jumps 19%, Swings from Loss to $16M Profit Healthcare tech provider Omnicell rebounds with strong Q4 performance, posting $307M revenue and $0.34 EPS. Annual bookings up 8% to $923M, driven by XT Series adoption.

#OMCL Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

www.stocktitan.net/news/OMCL/omnicell-annou...

Omnicell Sets Q4 and Full Year 2024 Earnings Release Date for February 6 Healthcare automation leader Omnicell will report Q4 and full-year 2024 results on February 6, 2025, with an earnings call scheduled for 8:30 a.m. ET.

#OMCL Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

www.stocktitan.net/news/OMCL/omnicell-to-re...

Omnicell Launches OmniSphere: Revolutionary Cloud Platform Transforms Enterprise Medication Management Omnicell unveils OmniSphere, a groundbreaking cloud-native platform integrating enterprise robotics and smart devices for advanced medication management and security.

#OMCL Omnicell Announces OmniSphere

#news #stocks #StockMarket

www.stocktitan.net/news/OMCL/omnicell-annou...

#OMCL Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

www.stocktitan.net/news/OMCL/omnicell-to-pr...

NEWS: ( NASDAQ: #OMCL ) Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

#StockMarket #News

#OMCL Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

www.stocktitan.net/news/OMCL/omnicell-annou...

#OMCL Omnicell Announces Proposed Private Placement of $150 Million of Convertible Senior Notes

www.stocktitan.net/news/OMCL/omnicell-annou...

Just In: ( NASDAQ: #OMCL ) Omnicell Announces Third Quarter 2024 Results

#StockMarket #News

BREAKING NEWS: ( NASDAQ: #OMCL ) Omnicell Inc. (NASDAQ: OMCL) Making Surprising Moves in Thursday Session

#StockMarket #News

Just In: ( NASDAQ: #OMCL ) EnlivenHealth and Good Neighbor Pharmacy Seek to Empower Independent Pharmacies with New Clinical Scope of Practice and Reimbursement Solution

#StockMarket #News

NEWS: ( NASDAQ: #OMCL ) Omnicell Announces Second Quarter 2024 Results

#StockMarket #News